Log in to save to my catalogue

Double hit & double expressor lymphomas: a multicenter analysis of survival outcomes with CD19-direc...

Double hit & double expressor lymphomas: a multicenter analysis of survival outcomes with CD19-direc...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_f066f4cc9901447497b1c2cb2a352826

Double hit & double expressor lymphomas: a multicenter analysis of survival outcomes with CD19-directed CAR T-cell therapy

About this item

Full title

Double hit & double expressor lymphomas: a multicenter analysis of survival outcomes with CD19-directed CAR T-cell therapy

Publisher

London: Nature Publishing Group UK

Journal title

Blood cancer journal (New York), 2025-03, Vol.15 (1), p.43-7, Article 43

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Double-hit (DHL) and double expressor (DEL) DLBCL have poor prognosis with standard therapy but CART may overcome this poor prognostic impact. In this multicenter retrospective study, we sought to confirm this observation by evaluating survival outcomes among patients with relapsed/refractory DHL and DEL treated with CART and evaluate outcomes of r...

Alternative Titles

Full title

Double hit & double expressor lymphomas: a multicenter analysis of survival outcomes with CD19-directed CAR T-cell therapy

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_f066f4cc9901447497b1c2cb2a352826

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_f066f4cc9901447497b1c2cb2a352826

Other Identifiers

ISSN

2044-5385

E-ISSN

2044-5385

DOI

10.1038/s41408-025-01250-8

How to access this item